Literature DB >> 28395398

Poor quality of life as a predictor of survival among thalassemia patients in Iran.

Shahab Rezaeian1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28395398      PMCID: PMC5434223          DOI: 10.4178/epih.e2017013

Source DB:  PubMed          Journal:  Epidemiol Health        ISSN: 2092-7193


× No keyword cloud information.
Dear Editor, An Iranian study was recently published in your prestigious journal, in which the aim was to determine the association between health-promoting lifestyles and quality of life (QoL) among a sample of 389 adult beta-thalassemia major (TM) patients [1]. The findings of that study revealed an unacceptable level of QoL among the thalassemia patients, in accordance with another finding from an Iranian study [2,3]. So far, none of the studies conducted on the survival rate of patients with thalassemia [4,5] have addressed the effect of QoL on survival in the discussion section. We conducted a retrospective cohort study enrolling 704 TM patients in 2016 in Shiraz, southern Iran. Our study aimed to identify changes in the survival rate of TM patients over the past two decades. Two different approaches, including a cohort analysis (Figure 1) and a period analysis (Table 1), were used to evaluate 20-year and 30-year survival rates and to compare changes in the survival trends in various time intervals between 1995 and 2016. The Cochran-Armitage test was used for trend analysis.
Figure 1.

The 20-, and 30-year survival rates of thalassemia major patients obtained at various time intervals, Iran, 1995-2016.

Table 1.

Trends in the 20- and 30-year survival rates of thalassemia major patients by period analysis, Iran, 2016

Period
p-value
1995-20002001-20052006-20102011-2016
No. of subjects196378519597-
Deaths12396066-
Mean probability of 20-year survival0.940.820.800.820.002
Mean probability of 30-year survival0.770.620.530.610.005
A downward trend was found in both the 20-year (p< 0.001), and 30-year (p< 0.001) survival rates of TM patients from 1995 to 2007, but an upward trend was found from 2007 through 2016 (Figure 1). The period analysis also indicated a downward trend in 20-year (p= 0.002), and 30-year (p= 0.005) survival rates from 1995 to 2016 (Table 1). With these results in mind, the poor QoL reported among Iranian TM patients [1-3] could explain the downward trend in the survival rate of TM patients found in this study. The results of a study conducted to characterize health-related QoL (HRQoL) and its related factors found that chronic diseases, such as thalassemia, were a significant determinant of HRQoL [6]. Another important factor related to QoL and life satisfaction is self-rated health status, which has been studied in the general population [7] and among subjects with a chronic illness [8]. In conclusion, it is suggested that factors affecting QoL should be addressed in future studies to obtain important information for policymakers to improve the QoL in this population, thereby improving survival.
  8 in total

1.  Factors associated with self-rated health status in Southwestern Iran: a population-based study.

Authors:  N Maharlouei; M Akbari; M Khabbaz Shirazy; D Yazdanpanah; K B Lankarani
Journal:  Public Health       Date:  2016-08-03       Impact factor: 2.427

2.  Survival analysis and its associated factors of Beta thalassemia major in hamadan province.

Authors:  Reza Zamani; Salman Khazaei; Shahab Rezaeian
Journal:  Iran J Med Sci       Date:  2015-05

3.  Health Related Quality of Life, Depression, Anxiety and Stress in Patients with Beta-Thalassemia Major.

Authors:  M Adib-Hajbaghery; M Ahmadi; Poormansouri S
Journal:  Iran J Ped Hematol Oncol       Date:  2015-12-10

4.  Associations between a health-promoting lifestyle and quality of life among adults with beta-thalassemia major.

Authors:  Aghbabak Maheri; Roya Sadeghi; Davoud Shojaeizadeh; Azar Tol; Mehdi Yaseri; Mojtaba Ebrahimi
Journal:  Epidemiol Health       Date:  2016-11-15

5.  Life and health satisfaction in the adult population of Iran.

Authors:  Rajabali Daroudi; Arash Rashidian; Hojjat Zeraati; Alireza Oliyaeemanesh; Ali Akbari Sari
Journal:  Epidemiol Health       Date:  2016-11-03

6.  Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran.

Authors:  Ali Kazemi Karyani; Arash Rashidian; Sarar Emamgholipour Sefiddashti; Ali Akbari Sari
Journal:  Epidemiol Health       Date:  2016-10-26

7.  Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.

Authors:  Meysam Seyedifar; Farid Abedin Dorkoosh; Amir Ali Hamidieh; Majid Naderi; Hossein Karami; Mehran Karimi; Masoomeh Fadaiyrayeny; Masoumeh Musavi; Sanaz Safaei; Mohammad Mahdi Ahmadian-Attari; Molouk Hadjibabaie; Abdol Majid Cheraghali; Ali Akbari Sari
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

8.  Analysis of survival data in thalassemia patients in Shiraz, Iran.

Authors:  Abdolreza Rajaeefard; Mahmoud Hajipour; Hamid Reza Tabatabaee; Jafar Hassanzadeh; Shahab Rezaeian; Zahra Moradi; Mehdi Sharafi; Mohsen Shafiee; Ali Semati; Sanaz Safaei; Maryam Soltani
Journal:  Epidemiol Health       Date:  2015-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.